Poor Long-term Clinical Outcomes & Health-Related Quality of Life in Dermatomyositis & Polymyositis

Dermatomyositis (DM) and polymyositis (PM) are rare autoimmune inflammatory myopathies characterized by muscle weakness and multiple extra-muscular manifestations that have detrimental impact on patients’ lives. Despite various therapies used in clinical practice, a large proportion of patients do not achieve sustainable remission. There is a need to better understand the clinical and humanistic burden of DM and PM. This presentation is to review current data on the long-term disease outcomes and the true impact of DM and PM on patient’s health-related quality of life.

This presentation is sponsored by Kezar Life Sciences and presented by Dr. Rohit Aggarwal, MD, the Co-Director of the Myositis Center of University Pittsburgh. Follow Dr. Aggarwal on YouTube @Myositis

View the slides and additional resources about this webinar on our website at https://understandingmyositis.org/poor-long-term-clinical-outcomes-health-related-quality-of-life-in-dm-and-pm
Be the first to comment